edited by Monica Rinaldi, Section of Medical Biotechnology, Institute of Translational Pharmacology )IFT(, National Research Council )CNR(, Rome, Italy(, Daniela Fioretti, Section of Medical Biotechnology, Institute of Translational Pharmacology )IFT(, National Research Council )CNR(, Rome, Italy(, Sandra Iurescia, Section of Medical Biotechnology, Institute of Translational Pharmacology )IFT(, National Research Council )CNR(, Rome, Italy(
Third Edition.
xi, 308 pages : illustrations )some color(, still photographic color images
Methods in molecular biology,1064-3745 ;1143
Springer protocols,1949-2448
Series: Methods in molecular biology )Clifton, N.J.( ;v. 1143,1064-3745
Series: Springer protocols )Series(1949-2448
"MIMB 1143."
A blueprint for DNA vaccine design /Sandra Iurescia, Daniela Fioretti, and Monica Rinaldi --Enhancement of plasmid-mediated transgene expression /Daniela Fioretti, Sandra Iurescia, and Monica Rinaldi --Strategies for improving DNA vaccine performance/Sandra Iurescia, Daniela Fioretti, and Monica Rinaldi --Enhancement of DNA vaccine efficacy by intracellular targeting strategies /Elisabete Borges Freitas ]and four others[ --Progresses in DNA-based heterologous prime-boost immunization strategies /Ronald J. Jackson, David B. Boyle, and Charani Ranasinghe --Development of antibiotic-free selection system for safer DNA vaccination /Jeremy M. Luke, Aaron E. Carnes, and James A. Williams --Electroporation-based DNA delivery technology : methods for gene electrotransfer to skin /Anita Gothelf and Julie Gehl --DNA vaccination in skin enhanced by electroporation /Kate E. Broderick, Amir S. Khan, and Niranjan Y. Sardesai --Intradermal vaccination by DNA tattooing /Joost H. van den Berg ]and four others[ --Microneedle applications for DNA vaccine delivery to the skin /Hae-yong Seok ]and three others[ --Multivalent DNA-based vectors for DNA vaccine delivery /Young Hoon Roh ]and three others[ --Superparamagnetic nanoparticle delivery of DNA vaccine /Fatin Nawwab Al-Deen ]and three others[ --Plasmid fermentation process for DNA immunization applications /Aaron E. Carnes and James A. Williams --Pharmaceutical grade large-scale plasmid DNA manufacturing process /Marco Schmeer and Martin Schleef --Protective and therapeutic DNA vaccination against allergic diseases /Almedina Isakovic ]and three others[ --Immunotherapy for Alzheimer's disease : DNA- and protein-based epitope vaccines /Hayk Davtyan, Irina Petrushina, and Anahit Ghochikyan --Tetravalent DNA vaccine product as a vaccine candidate against Dengue /Kevin R. Porter, Nimfa Teneza-Mora, and Kanakatte Raviprakash --DNA vaccination as a treatment for chronic kidney disease /Yuan Min Wang and Stephen I. Alexander.